Compugen Cash Flow Conversion Efficiency

Latest as of December 2022: 0.056x

Compugen cash flow conversion efficiency. Based on the latest financial reports, Compugen (CGEN) has a cash flow conversion efficiency ratio of 0.056x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA4.33 Million ≈ $11.60K USD) by net assets (ILA77.68 Million ≈ $208.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Compugen (1999–2025)

Cash flow conversion efficiency of Compugen from 1999 to 2025. This chart illustrates how Compugen's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Compugen (CGEN) stock price for real-time trading data and today's change.

Compugen Cash Flow Conversion Ratio Explained

Compugen cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Compugen Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Compugen ranked by their cash flow conversion efficiency. Also see market cap of Compugen for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Inesa Intelligent Tech Inc B SHG:900901	-0.009x
Kuen Chaang Uppertech TWO:6265	-0.217x
Samjin Pharm KO:005500	-0.005x
Millennial Potash Corp. V:MLP	-0.041x
Home Center Holdings Co.Ltd KQ:060560	0.000x
Curexo Inc KQ:060280	-0.016x
DCX Systems Limited NSE:DCXINDIA	0.002x
UmweltBank AG XETRA:UBK	-0.132x

Annual Cash Flow Conversion Efficiency for Compugen (1999–2025)

The table below shows the annual cash flow conversion efficiency of Compugen from 1999 to 2025. Review CGEN free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA102.73 Million ≈ $275.42K	ILA31.63 Million ≈ $84.81K	0.308x	-65.91%
2024-12-31	ILA54.91 Million ≈ $147.22K	ILA49.60 Million ≈ $132.99K	0.903x	+265.02%
2023-12-31	ILA65.56 Million ≈ $175.76K	ILA-35.89 Million ≈ $-96.21K	-0.547x	-24.65%
2022-12-31	ILA77.68 Million ≈ $208.26K	ILA-34.11 Million ≈ $-91.46K	-0.439x	-105.95%
2021-12-31	ILA106.69 Million ≈ $286.04K	ILA-22.75 Million ≈ $-60.99K	-0.213x	+9.81%
2020-12-31	ILA119.78 Million ≈ $321.13K	ILA-28.32 Million ≈ $-75.92K	-0.236x	+67.51%
2019-12-31	ILA38.32 Million ≈ $102.74K	ILA-27.89 Million ≈ $-74.77K	-0.728x	-103.92%
2018-12-31	ILA37.24 Million ≈ $99.85K	ILA-13.29 Million ≈ $-35.63K	-0.357x	+65.90%
2017-12-31	ILA29.30 Million ≈ $78.54K	ILA-30.66 Million ≈ $-82.19K	-1.046x	-235.38%
2016-12-31	ILA63.52 Million ≈ $170.29K	ILA-19.82 Million ≈ $-53.13K	-0.312x	-9.54%
2015-12-31	ILA89.90 Million ≈ $241.01K	ILA-25.61 Million ≈ $-68.65K	-0.285x	-170.78%
2014-12-31	ILA105.97 Million ≈ $284.12K	ILA-11.15 Million ≈ $-29.89K	-0.105x	+47.90%
2013-12-31	ILA31.89 Million ≈ $85.49K	ILA-6.44 Million ≈ $-17.26K	-0.202x	+67.10%
2012-12-31	ILA17.67 Million ≈ $47.38K	ILA-10.85 Million ≈ $-29.08K	-0.614x	-29.93%
2011-12-31	ILA19.58 Million ≈ $52.50K	ILA-9.25 Million ≈ $-24.80K	-0.472x	-212.23%
2010-12-31	ILA28.29 Million ≈ $75.83K	ILA-4.28 Million ≈ $-11.47K	-0.151x	+44.39%
2009-12-31	ILA27.40 Million ≈ $73.45K	ILA-7.45 Million ≈ $-19.98K	-0.272x	+72.82%
2008-12-31	ILA10.00 Million ≈ $26.82K	ILA-10.01 Million ≈ $-26.84K	-1.001x	-105.79%
2007-12-31	ILA17.29 Million ≈ $46.34K	ILA-8.41 Million ≈ $-22.54K	-0.486x	-26.03%
2006-12-31	ILA25.74 Million ≈ $69.00K	ILA-9.93 Million ≈ $-26.63K	-0.386x	-25.94%
2005-12-31	ILA36.25 Million ≈ $97.18K	ILA-11.11 Million ≈ $-29.78K	-0.306x	-24.48%
2004-12-31	ILA49.57 Million ≈ $132.88K	ILA-12.20 Million ≈ $-32.71K	-0.246x	-164.19%
2003-12-31	ILA59.81 Million ≈ $160.34K	ILA-5.57 Million ≈ $-14.94K	-0.093x	+29.28%
2002-12-31	ILA68.88 Million ≈ $184.67K	ILA-9.08 Million ≈ $-24.33K	-0.132x	-11.08%
2001-12-31	ILA80.06 Million ≈ $214.64K	ILA-9.50 Million ≈ $-25.46K	-0.119x	-78.69%
2000-12-31	ILA92.51 Million ≈ $248.02K	ILA-6.14 Million ≈ $-16.46K	-0.066x	+85.27%
1999-12-31	ILA12.79 Million ≈ $34.28K	ILA-5.76 Million ≈ $-15.45K	-0.451x	--

About Compugen

TA:CGEN Israel Biotechnology

Market Cap

$159.88 Million

ILA59.64 Billion ILA

Market Cap Rank

#17228 Global

#209 in Israel

Share Price

ILA630.50

Change (1 day)

+0.67%

52-Week Range

ILA462.80 - ILA924.00

All Time High

ILA6613.00